Skip to main content
. Author manuscript; available in PMC: 2017 Mar 21.
Published in final edited form as: Analyst. 2016 Mar 21;141(6):2016–2022. doi: 10.1039/c5an01873k

Figure 9.

Figure 9

T1-weighted images of the abdomen taken using saline solution as the negative control (left) and 30 minutes after the oral administration of the PEG-coated Gd@PBNP suspension (right), showing an unequivocal enhancement of the positive contrast (i.e. T1-weighted) of MRI signals in the abdomen